يعرض 1 - 10 نتائج من 15 نتيجة بحث عن '"Morgillo F."', وقت الاستعلام: 0.91s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Quality of Life Analysis of TORCH, a Randomized Trial Testing First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Chemotherapy in Advanced Non-Small-Cell Lung Cancer

    المؤلفون: Di Maio M, Leighl NB, Gallo C, Feld R, Ciardiello F, Butts C, Maione P, Gebbia V, Morgillo F, Wierzbicki R, Favaretto A, Alam Y, Cinieri S, Siena S, Bianco R, Riccardi F, Spatafora M, Ravaioli A, Felletti R, Fregoni V, Genestreti G, Rossi A, Mancuso G, Fasano M, Morabito A, Tsao MS, Signoriello S, Perrone F, Gridelli C, TORCH Investigators, Calabro' L

    المساهمون: Di Maio, M, Leighl, Nb, Gallo, C, Feld, R, Ciardiello, F, Butts, C, Maione, P, Gebbia, V, Morgillo, F, Wierzbicki, R, Favaretto, A, Alam, Y, Cinieri, S, Siena, S, Bianco, R, Riccardi, F, Spatafora, M, Ravaioli, A, Felletti, R, Fregoni, V, Genestreti, G, Rossi, A, Mancuso, G, Fasano, M, Morabito, A, Tsao, M, Signoriello, S, Perrone, F, Gridelli, C, Torch, Investigator, Calabro', L

    مصطلحات موضوعية: Advanced non-small-cell lung cancer, Chemotherapy, EGFR, Erlotinib, First-line treatment, Health-related quality of life, Randomized trial

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/23154555; info:eu-repo/semantics/altIdentifier/wos/WOS:000311387700022; volume:7; issue:12; firstpage:1830; lastpage:1844; numberofpages:15; journal:JOURNAL OF THORACIC ONCOLOGY; http://hdl.handle.net/11392/2492624Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84870327842; https://www.jto.org/article/S1556-0864Test(15)33167-1/fulltext; https://www.jto.org/action/showPdf?pii=S1556-0864Test(15)33167-1

    الإتاحة: https://doi.org/10.1097/JTO.0b013e318275b327Test
    http://hdl.handle.net/11392/2492624Test
    https://www.jto.org/article/S1556-0864Test(15)33167-1/fulltext
    https://www.jto.org/action/showPdf?pii=S1556-0864Test(15)33167-1

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I-II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer

    المؤلفون: Morgillo F, Fasano M, Della Corte CM, Sasso FC, Papaccio F, Viscardi G, Esposito G, Di Liello R, Normanno N, Capuano A, Berrino L, Vicidomini G, Fiorelli A, Santini M, Ciardiello F.

    المساهمون: Morgillo, F, Fasano, M, Della Corte, Cm, Sasso, Fc, Papaccio, F, Viscardi, G, Esposito, G, Di Liello, R, Normanno, N, Capuano, A, Berrino, L, Vicidomini, G, Fiorelli, A, Santini, M, Ciardiello, F.

    مصطلحات موضوعية: LKB1, NSCLC, Erlotinib, Metformin

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28761738; info:eu-repo/semantics/altIdentifier/wos/WOS:000408040300001; volume:2; firstpage:1; lastpage:7; numberofpages:7; journal:ESMO OPEN; https://hdl.handle.net/11386/4752925Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85043486943; https://www.sciencedirect.com/science/article/pii/S2059702920324431?via=ihubTest

    الإتاحة: https://doi.org/10.1136/esmoopen-2016-000132Test
    https://hdl.handle.net/11386/4752925Test
    https://www.sciencedirect.com/science/article/pii/S2059702920324431?via=ihubTest

    View record in BASE

    أضف إلى المفضلة
  3. 3
    Quality of Life Analysis of TORCH, a Randomized Trial Testing First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Chemotherapy in Advanced Non-Small-Cell Lung Cancer

    المؤلفون: Di Maio, M, Leighl, Nb, Gallo, C, Feld, R, Ciardiello, F, Butts, C, Maione, P, Gebbia, V, Morgillo, F, Wierzbicki, R, Favaretto, A, Alam, Y, Cinieri, S, Siena, S, Bianco, R, Riccardi, F, Spatafora, M, Ravaioli, A, Felletti, R, Fregoni, V, Genestreti, G, Rossi, A, Mancuso, G, Fasano, M, Morabito, A, Tsao, Ms, Signoriello, S, Perrone, F, Gridelli, C, Torch, Investigators, Calabro', L

    المساهمون: Di Maio, M., Leighl, N. B., Gallo, C., Feld, R., Ciardiello, F., Butts, C., Maione, P., Gebbia, V., Morgillo, F., Wierzbicki, R., Favaretto, A., Alam, Y., Cinieri, S., Siena, S., Bianco, Roberto, Riccardi, F., Spatafora, M., Ravaioli, A., Felletti, R., Fregoni, V., Genestreti, G., Rossi, A., Mancuso, G., Fasano, M., Morabito, A., Tsao, M. S., Signoriello, S., Perrone, F., Gridelli, C., Di Maio, M, Leighl, N, Gallo, C, Feld, R, Ciardiello, F, Butts, C, Maione, P, Gebbia, V, Morgillo, F, Wierzbicki, R, Favaretto, A, Alam, Y, Cinieri, S, Siena, S, Bianco, R, Riccardi, F, Spatafora, M, Ravaioli, A, Felletti, R, Fregoni, V, Genestreti, G, Rossi, A, Mancuso, G, Fasano, M, Morabito, A, Tsao, M, Signoriello, S, Perrone, F, Gridelli, C, Leighl, Nb

    مصطلحات موضوعية: Oncology, Male, erlotinib, Lung Neoplasms, Health-related quality of life, NSCLC, chemotherapy, Deoxycytidine, law.invention, Randomized controlled trial, Quality of life, law, Carcinoma, Non-Small-Cell Lung, Surveys and Questionnaires, Antineoplastic Combined Chemotherapy Protocols, Surveys and Questionnaire, Quality of life analysis of TORCH, Erlotinib Hydrochloride, Prognosis, humanities, Research Design, Advanced non–small-cell lung cancer, Carcinoma, Squamous Cell, Female, Erlotinib, Randomized trial, medicine.drug, Human, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Prognosi, EGFR, First-line treatment, first-line erlotinib, second-line cisplatin/gemcitabine chemotherapy, Adenocarcinoma, NO, Follow-Up Studie, Internal medicine, advanced non-small-cell lung cancer, medicine, Humans, Lung cancer, Advanced non-small-cell lung cancer, Chemotherapy, Quality of life analysis of TORCH , first-line erlotinib , second-line cisplatin/gemcitabine chemotherapy, advanced non-small-cell lung cancer, Aged, Neoplasm Staging, Salvage Therapy, Antineoplastic Combined Chemotherapy Protocol, business.industry, Questionnaire, Cancer, Quinazoline, medicine.disease, Interim analysis, Gemcitabine, Surgery, Lung Neoplasm, quality of life, Quinazolines, Carcinoma, Large Cell, Cisplatin, Neoplasm Recurrence, Local, business, Follow-Up Studies

    وصف الملف: ELETTRONICO

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::297e0496785c9c52225a929dbddaa27eTest
    http://hdl.handle.net/11588/519780Test


    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Delivery optimization of erlotinib according to toxicity: may clinical practice go beyond research?

    المؤلفون: Passaro A, Fasano M, Morgillo F, Cantile F, Alesini D, Pellegrino A, Cortesi E, Ciardiello F., Bria, Emilio

    المساهمون: Passaro, A, Fasano, M, Bria, Emilio, Morgillo, F, Cantile, F, Alesini, D, Pellegrino, A, Cortesi, E, Ciardiello, F.

    مصطلحات موضوعية: Lung cancer, Erlotinib, toxicity

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/23453130; volume:80; issue:3; firstpage:352; lastpage:353; numberofpages:2; journal:LUNG CANCER; http://hdl.handle.net/11562/878191Test

    الإتاحة: http://hdl.handle.net/11562/878191Test

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    First-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced Non Small Cell Lung Cancer. The TORCH randomised trial.

    المؤلفون: Gridelli C, Ciardiello F, Gallo C, Feld R, Butts C, Gebbia V, Maione P, Morgillo F, Genestreti G, Favaretto A, Leighl N, Wierzbicki R, Cinieri S, Alam Y, Siena S, Felletti R, Riccardi F, Mancuso G, Rossi A, Cantile F, Tsao M. S, Saieg M, da Cunha Santos G, Piccirillo MC, Di Maio M, Morabito A, Perrone F., TORTORA, GIAMPAOLO

    المساهمون: Gridelli, C, Ciardiello, F, Gallo, C, Feld, R, Butts, C, Gebbia, V, Maione, P, Morgillo, F, Genestreti, G, Favaretto, A, Leighl, N, Wierzbicki, R, Cinieri, S, Alam, Y, Siena, S, Tortora, Giampaolo, Felletti, R, Riccardi, F, Mancuso, G, Rossi, A, Cantile, F, Tsao, M. S., Saieg, M, da Cunha Santos, G, Piccirillo, Mc, Di Maio, M, Morabito, A, Perrone, F.

    مصطلحات موضوعية: NSCLC, Erlotinib, Chemotherapy

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/22778317; info:eu-repo/semantics/altIdentifier/wos/WOS:000308082300016; volume:30; issue:24; firstpage:3002; lastpage:3011; numberofpages:10; journal:JOURNAL OF CLINICAL ONCOLOGY; http://hdl.handle.net/11562/429761Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84865154870

    الإتاحة: http://hdl.handle.net/11562/429761Test

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Quality of Life Analysis of TORCH, a Randomized Trial Testing First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Chemotherapy in Advanced Non-Small-Cell Lung Cancer.

    المؤلفون: Di Maio M., Leighl N. B., Gallo C., Feld R., Ciardiello F., Butts C., Maione P., Gebbia V., Morgillo F., Wierzbicki R., Favaretto A., Alam Y., Cinieri S., Siena S., Riccardi F., Spatafora M., Ravaioli A., Felletti R., Fregoni V., Genestreti G., Rossi A., Mancuso G., Fasano M., Morabito A., Tsao M. S., Signoriello S., Perrone F., Gridelli C., BIANCO, ROBERTO

    المساهمون: Di Maio, M., Leighl, N. B., Gallo, C., Feld, R., Ciardiello, F., Butts, C., Maione, P., Gebbia, V., Morgillo, F., Wierzbicki, R., Favaretto, A., Alam, Y., Cinieri, S., Siena, S., Bianco, Roberto, Riccardi, F., Spatafora, M., Ravaioli, A., Felletti, R., Fregoni, V., Genestreti, G., Rossi, A., Mancuso, G., Fasano, M., Morabito, A., Tsao, M. S., Signoriello, S., Perrone, F., Gridelli, C.

    مصطلحات موضوعية: NSCLC, erlotinib, chemotherapy, quality of life

    وصف الملف: ELETTRONICO

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/23154555; info:eu-repo/semantics/altIdentifier/wos/WOS:000311387700022; volume:7; issue:12; firstpage:1830; lastpage:1844; numberofpages:15; journal:JOURNAL OF THORACIC ONCOLOGY; http://hdl.handle.net/11588/519780Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84870327842

    الإتاحة: http://hdl.handle.net/11588/519780Test

    View record in BASE

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: A randomized phase II study

    المؤلفون: Gridelli C., Morgillo F., Favaretto A., de Marinis F., Chella A., Cerea G., Mattioli R., Tortora G., Rossi A., Fasano M., Pasello G., Ricciardi S., Maione P., di Maio M., Ciardiello F.

    المساهمون: Gridelli, C., Morgillo, F., Favaretto, A., de Marinis, F., Chella, A., Cerea, G., Mattioli, R., Tortora, G., Rossi, A., Fasano, M., Pasello, G., Ricciardi, S., Maione, P., di Maio, M., Ciardiello, F.

    مصطلحات موضوعية: Elderly, Erlotinib, Gemcitabine, NSCLC, Sorafenib, Adenocarcinoma, Bronchiolo-Alveolar, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocol, Benzenesulfonate, Carcinoma, Large Cell, Non-Small-Cell Lung, Squamous Cell, Deoxycytidine, Erlotinib Hydrochloride, Feasibility Studie, Female, Follow-Up Studie, Human, Lung Neoplasm, Male, Niacinamide, Phenylurea Compound, Pyridine, Quinazoline, Survival Rate, Treatment Outcome

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/21212155; info:eu-repo/semantics/altIdentifier/wos/WOS:000292048500008; volume:22; issue:7; firstpage:1528; lastpage:1534; numberofpages:7; journal:ANNALS OF ONCOLOGY; http://hdl.handle.net/11577/3368192Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-79959695837

    الإتاحة: https://doi.org/10.1093/annonc/mdq630Test
    http://hdl.handle.net/11577/3368192Test

    View record in BASE

    أضف إلى المفضلة
  8. 8
    First-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced Non Small Cell Lung Cancer. The TORCH randomised trial

    المؤلفون: Gridelli, C, Ciardiello, F, Gallo, C, Feld, R, Butts, C, Gebbia, V, Maione, P, Morgillo, F, Genestreti, G, Favaretto, A, Leighl, N, Wierzbicki, R, Cinieri, S, Alam, Y, Siena, S, Tortora, Giampaolo, Felletti, R, Riccardi, F, Mancuso, G, Rossi, A, Cantile, F, Tsao, M. S., Saieg, M, da Cunha Santos, G, Piccirillo, Mc, Di Maio, M, Morabito, A, Perrone, F.

    مصطلحات موضوعية: NSCLC, Erlotinib, Chemotherapy

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______1943::9702ca5a4b94e7701c59fccac64a5595Test
    http://hdl.handle.net/11562/429761Test


    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    Antitumour efficacy of MEK inhibitors in human lung cancer cells and their derivatives with acquired resistance to different tyrosine kinase inhibitors.

    المؤلفون: Morgillo, F.1, Cascone, T.1,2, D'Aiuto, E.3, Martinelli, E.3, Troiani, T.1, Saintigny, P.2, De Palma, R.3, Heymach, J. V.2, Berrino, L.4, Tuccillo, C.5, Ciardiello, F.1

    المصدر: British Journal of Cancer. 7/26/2011, Vol. 105 Issue 3, p382-392. 11p. 1 Chart, 6 Graphs.

    مصطلحات موضوعية: *LUNG cancer, *PROTEIN-tyrosine kinases, *PROTEIN microarrays, *CELL proliferation, *XENOGRAFTS, *CELL migration

    النص الكامل

    أضف إلى المفضلة
  10. 10
    Synergistic antitumor activity of sorafenib in combination with epidermal growth factor receptor inhibitors in colorectal and lung cancer cells

    المؤلفون: Donata Vitagliano, Erika Martinelli, Anna Capasso, Maria Pia Morelli, Ferdinando De Vita, Concetta Tuccillo, Massimo Santoro, Fortunato Ciardiello, Michele Orditura, Floriana Morgillo, Gabriella Rodolico, Teresa Troiani, Liberato Berrino, Loredana Vecchione, S. Gail Eckhardt

    المساهمون: Martinelli, Erika, Troiani, Teresa, Morgillo, Floriana, Rodolico, G, Vitagliano, D, Morelli, Mp, Tuccillo, C, Vecchione, L, Capasso, A, Orditura, Michele, DE VITA, Ferdinando, Eckhardt, Sg, Santoro, M, Berrino, Liberato, Ciardiello, Fortunato, Martinelli, E., Troiani, T., Morgillo, F., Rodolico, G., Vitagliano, Donata, Morelli, M. P., Tuccillo, C., Vecchione, L., Capasso, A., Orditura, M., De Vita, F., Eckhardt, S. G., Santoro, Massimo, Berrino, L., Ciardiello, F.

    المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research. 16(20)

    مصطلحات موضوعية: Cancer Research, Lung Neoplasms, Pyridines, Cetuximab, Metastasis, Mice, Cell Movement, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Epidermal growth factor receptor, Erlotinib Hydrochloride, biology, Benzenesulfonates, Antibodies, Monoclonal, Drug Synergism, Sorafenib, ErbB Receptors, Oncology, Female, Erlotinib, Colorectal Neoplasms, HT29 Cells, medicine.drug, Signal Transduction, Niacinamide, medicine.medical_specialty, Mice, Nude, Cell Growth Processes, Antibodies, Monoclonal, Humanized, Internal medicine, Cell Line, Tumor, medicine, Animals, Humans, neoplasms, Protein Kinase Inhibitors, business.industry, Phenylurea Compounds, Cancer, medicine.disease, HCT116 Cells, Xenograft Model Antitumor Assays, digestive system diseases, Endocrinology, Receptors, Vascular Endothelial Growth Factor, Cancer cell, Cancer research, biology.protein, Quinazolines, business

    وصف الملف: STAMPA

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53cd2101e4ac2c5fadaa1d4898567756Test
    https://pubmed.ncbi.nlm.nih.gov/20810384Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث